Endoscopic pancreatic stenting

内镜下胰腺支架置入术
  • 文章类型: Journal Article
    建议将内镜治疗和体外冲击波碎石术(ESWL)作为治疗胰管结石的首选方法。内窥镜治疗通常使用内窥镜胰腺括约肌切开术(EPST)进行。在这里,我们报告了我们实施治疗方案的经验,结合内镜治疗和无EPST的ESWL,胰管结石.每3个月执行住院治疗计划,并进行一定数量的ESWL,并植入或更换内镜下胰腺支架(EPS)。最后,当植入10-Fr支架后取出结石并将其压碎至约3mm或自发性结石排出后,治疗终止。本研究包括8名患者;结石消失的中位时间为208.5天。住院治疗周期的中位数,内镜逆行胰胆管造影术,和ESWL会话分别为2.5、3和3。所有患者均未发生严重不良事件。因此,联合ESWL和无EPST的EPS可以安全地治疗胰管结石。
    Endoscopic therapy and extracorporeal shock wave lithotripsy (ESWL) are recommended as the first choice in treating pancreatolithiasis. Endoscopic therapy is generally performed using endoscopic pancreatic sphincterotomy (EPST). Herein, we report our experience implementing a treatment protocol, combining endoscopic therapy and ESWL without EPST, for pancreatolithiasis. The inpatient treatment plan was performed every 3 months with a set number of sessions of ESWL with endoscopic pancreatic stenting (EPS) implanted or replaced. Finally, treatment was terminated when the stone was removed after implantation of a 10-Fr stent and crushed to approximately 3 mm or after spontaneous stone discharge. Eight patients were included in this study; the median time to stone disappearance was 208.5 days. The median number of inpatient treatment cycles, endoscopic retrograde cholangiopancreatography, and ESWL sessions was 2.5, 3, and 3, respectively. No serious adverse events were observed in all patients. Therefore, combining ESWL and EPS without EPST can safely treat pancreatolithiasis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:支架诱导的导管改变(SIDC)是慢性胰腺炎(CP)患者内镜下胰腺支架置入术(EPS)的并发症。然而,与S型胰腺塑料支架(PS)和大口径PS相关的SIDC的评价,例如10Fr,是有限的。本研究旨在分析CP患者与10-FrS型PS相关的主胰管(MPD)SIDC。
    方法:在2008年1月至2021年12月之间,对132例CP患者进行了回顾性分析,其中通过EPS安装了10-FrS型PS。检查了SIDC的发生率,并研究了有和没有SIDC的患者的临床特征,包括检测到的SIDC的结果。
    结果:在132例患者中,有41例患者(31.1%)在与MPD中PS尖端或远端皮瓣一致的部位证实了EPS期间支架引起的导管改变。所有患者在SIDC发展过程中无症状。MPD的形态变化被检测为升高(75.6%)或带有狭窄变化(24.4%)。在第一次10-FrPS安装后,总共开发了90.2%的SIDC。在有和没有SIDC的患者之间没有发现显着差异。SIDC连续PS分期付款的结果显示了持久性和次要变化。
    结论:支架诱导的导管改变相关的10-FrPS安装在不到三分之一的患者中进行,表明从早期阶段开始SIDC的发病率和可能的发展。作为并发症,应更加重视SIDC。
    OBJECTIVE: Stent-induced ductal change (SIDC) is a complication of endoscopic pancreatic stenting (EPS) in patients with chronic pancreatitis (CP). However, the evaluation of SIDC associated with S-type pancreatic plastic stent (PS) and large-caliber PS, such as 10 Fr, is limited. This study aimed to analyze the SIDC of the main pancreatic duct (MPD) associated with 10-Fr S-type PS in patients with CP.
    METHODS: Between January 2008 and December 2021, 132 patients with CP in whom a 10-Fr S-type PS had been installed by EPS were retrospectively reviewed. The SIDC incidence rate was examined, and the clinical features of patients with and without SIDC were investigated, including the outcomes for detected SIDC.
    RESULTS: Stent-induced ductal change during EPS was confirmed in 41 patients (31.1%) of 132 patients at a site coincident with the PS tip or distal flap in the MPD. All patients were asymptomatic during the development of SIDC. Morphological changes in the MPD were detected as elevated (75.6%) or bearing stricture changes (24.4%). A total of 90.2% of SIDC developed after the first 10-Fr PS installation. No significant differences were noted between the patients with and without SIDC. The outcomes of continued PS installment for SIDC showed persistence and secondary change.
    CONCLUSIONS: Stent-induced ductal change-associated 10-Fr PS installation was performed in just under one-third of the patients, indicating a substantial incidence rate and a possible development of SIDC from early stages onwards. More emphasis should be placed on SIDC as the complication.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    Pancreatic pseudocyst-portal vein (PP-PV) fistula, mostly occurring after pseudocyst formation following acute/chronic pancreatitis, is a rare but life-threatening condition. The majority of treatments are based on conservative or surgical interventions. We report the case of a 70-year-old man with a PP-PV fistula and PV thrombosis. We adopted conservative treatment at first due to his mild symptoms. However, after resuming food intake, the patient had severe abdominal pain. Following endoscopic retrograde cholangiopancreatography, we found that the pseudocyst was connected with the PV through the fistula. Subsequently, an endoscopic nasopancreatic drainage (ENPD) catheter was inserted into the main pancreatic duct to establish pancreatic drainage, which resulted in a decrease in the abdominal pain. After the ENPD tube had been exchanged for endoscopic pancreatic stenting, his abdominal pain did not recur. Therefore, this case demonstrated endoscopic treatment as an effective treatment option for PP-PV fistula.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

  • 文章类型: Case Reports
    The diagnostic evaluation of pancreatic injuries has improved dramatically in recent years. However, it is sometimes difficult to diagnose pancreatic injuries. Surgical treatment after delayed diagnosis is associated with increased risks of mortality and morbidity. A 47-year-old man was referred to our emergency department after experiencing blunt abdominal trauma 5 d earlier. The patient was diagnosed with a grade-III pancreatic injury. His hemodynamic status remained stable. He was managed successfully using endoscopic pancreatic stenting and percutaneous drainage catheter insertion.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

       PDF(Pubmed)

公众号